Infectious Diseases

Responsive biometrics support for high-stakes infectious disease trials

Adherence to CDSIC regulatory standards

Rapid epidemiological modeling to simulate the spread of emerging infectious threats worldwide

Pharmaceutical companies face growing pressure to accelerate the development of vaccines and anti-infective therapies. Since 2015, Intego Clinical has provided specialized biometrics support for infectious disease studies. No matter the scope or stage of development, our experienced team consistently delivers with speed, reliability, and a commitment to exceeding client expectations.

Our Strengths in Infectious Disease Research

More than 10 years of experience supporting infectious disease trials, with a strong focus on influenza and other respiratory pathogens
Deep familiarity with CDISC standards and global regulatory requirements
Proven experience managing clinical trials involving vulnerable and pediatric populations
Ability to support studies with high data volume, complex parameters, and advanced endpoint designs
Strong understanding of genetics, immunology, and virology to inform data strategy and analysis
Rapid epidemiological modeling capabilities to simulate the spread of COVID-19 and other emerging pathogens across diverse geographic and socio-economic settings

Each year, up to 45 million people worldwide are affected by influenza, and infectious diseases remain one of the leading causes of death, according to the World Health Organization (WHO). With rising antibiotic resistance and the rapid emergence of new viral strains, the need for innovative therapies and the ability to evaluate them quickly has never been more urgent.

The COVID-19 pandemic publicly displayed the critical role of infectious disease clinical research and the demand for faster, more complex data analysis. As pharma and biotech companies race to deliver meaningful results, choosing the right biometrics CRO is essential. Sponsors need a resourceful and responsive partner like Intego Clinical, with the agility to adapt and the expertise to drive studies to successful completion.

Understanding the Spread of Outbreaks Through Real-World Data

Real-world data plays a critical role in uncovering patterns during infectious disease outbreaks. During the COVID-19 pandemic, for instance, Intego Clinical applied advanced machine learning and topological data analysis to study how the virus spread across more than 3,000 U.S. counties over time.

By analyzing time-series data, we uncovered structural patterns and identified hidden variables that contributed to similar outbreak dynamics across geographically and socioeconomically diverse regions. This work not only deepened our understanding of COVID-19 transmission but also demonstrated the value of data-driven modeling in responding to future public health threats.

Learn more

Our Infectious Disease Expertise

At Intego Clinical, our team of experienced statistical programmers, data managers, and regulatory specialists are dedicated to helping you analyze trial endpoints while maintaining full compliance with global standards. We understand the urgency and complexity of infectious disease research, and we deliver with consistency, clarity, and integrity.

Whether you need targeted support for a single study or a trusted long-term partner, Intego Clinical offers customized biometrics solutions designed to fit your goals and adapt to the evolving landscape of infectious disease trials.